These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 35804298

  • 21. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
    Fattorini L, Vincent V, Li B, Xiao Y, Varnerot A, Tortoli E, Piersimoni C, Mandler F, Mascellino MT, Iona E, Orefici G.
    J Chemother; 1996 Feb; 8(1):37-42. PubMed ID: 8835106
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan.
    Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0021824. PubMed ID: 38687080
    [Abstract] [Full Text] [Related]

  • 25. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug 04; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 26. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Klemens SP, DeStefano MS, Cynamon MH.
    Antimicrob Agents Chemother; 1992 Nov 04; 36(11):2413-7. PubMed ID: 1336945
    [Abstract] [Full Text] [Related]

  • 27. Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex.
    Tomioka H.
    Curr Drug Discov Technol; 2004 Dec 04; 1(4):255-68. PubMed ID: 16472242
    [Abstract] [Full Text] [Related]

  • 28. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J.
    J Antimicrob Chemother; 2019 Apr 01; 74(4):935-943. PubMed ID: 30649327
    [Abstract] [Full Text] [Related]

  • 29. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
    Fattorini L, Hu CQ, Jin SH, Santoro C, Tsang AY, Mascellino MT, Mandler F, Orefici G.
    Zentralbl Bakteriol; 1992 Apr 01; 276(4):512-20. PubMed ID: 1611208
    [Abstract] [Full Text] [Related]

  • 30. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
    Reisner BS, Woods GL, Popov VL.
    Int J Tuberc Lung Dis; 1997 Jun 01; 1(3):270-5. PubMed ID: 9432376
    [Abstract] [Full Text] [Related]

  • 31. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
    Schön T, Chryssanthou E.
    Int J Infect Dis; 2017 Feb 01; 55():122-124. PubMed ID: 28069470
    [Abstract] [Full Text] [Related]

  • 32. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, Young LS.
    Antimicrob Agents Chemother; 2001 Jan 01; 45(1):217-22. PubMed ID: 11120969
    [Abstract] [Full Text] [Related]

  • 33. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J, Egelund EF, Levin A, Totten SE, Boeree MJ, Mouton JW, Aarnoutse RE, Heifets LB, Peloquin CA, Daley CL.
    Am J Respir Crit Care Med; 2012 Sep 15; 186(6):559-65. PubMed ID: 22744719
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
    Mascellino MT, Iona E, Fattorini L, De Gregoris P, Hu CQ, Santoro C, Orefici G.
    J Chemother; 1991 Dec 15; 3(6):357-62. PubMed ID: 1840274
    [Abstract] [Full Text] [Related]

  • 35. Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
    Chang CL, Chen LC, Yu CJ, Hsueh PR, Chien JY.
    Int J Infect Dis; 2020 Sep 15; 98():33-40. PubMed ID: 32534139
    [Abstract] [Full Text] [Related]

  • 36. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J.
    Antimicrob Agents Chemother; 2016 Feb 15; 60(2):1097-105. PubMed ID: 26643335
    [Abstract] [Full Text] [Related]

  • 37. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG.
    Clin Infect Dis; 1998 Dec 15; 27(6):1401-5. PubMed ID: 9868650
    [Abstract] [Full Text] [Related]

  • 38. In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium.
    Yajko DM, Sanders CA, Madej JJ, Cawthon VL, Hadley WK.
    Antimicrob Agents Chemother; 1996 Mar 15; 40(3):743-9. PubMed ID: 8851604
    [Abstract] [Full Text] [Related]

  • 39. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method.
    Tomioka H, Saito H, Fujii K, Sato K, Hidaka T.
    Antimicrob Agents Chemother; 1993 Jan 15; 37(1):67-70. PubMed ID: 8431020
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.